Clinical Trial

Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the clinical efficacy of Shenbailing granules in improving quality of life and reducing cancer-related fatigue in a real-world setting, with the goal of providing clinical evidence for the use of Shenbailing granules in alleviating cancer-related fatigue among post-breast cancer surgery patients.
Trial Details
NCT Number NCT06881550
Lead Sponsor Caigang Liu
Conditions Breast Cancer
Enrollment 2,000 participants
Start Date 2024-12-30
Primary Completion 2025-12-10 (estimated)
Study Completion 2026-12-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-18